Physician profile
Aysel Atli
NPI 1912084617
$2,162.87
in general payments reported to CMS, 2019-2025
22 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $130 · 2021: $182 · 2022: $480 · 2023: $50.13 · 2024: $261 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $383.48 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $377.63 | 2019-2023 | Ajovy |
| Medtronic, INC. | $235.40 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $172.73 | 2022-2025 | Sprint Pns System |
| Boston Scientific Corporation | $142.71 | 2019-2025 | Wavewriter Alpha Prime 16, Artisan, Intracept |
| Lilly USA, LLC | $127.43 | 2019 | |
| Mdd US Operations, LLC | $108.69 | 2019 | |
| Collegium Pharmaceutical, INC. | $94.28 | 2021-2025 | Belbuca |
| Medtronic USA, INC. | $86.85 | 2019-2020 | |
| Abbvie INC. | $76.27 | 2022-2025 | |
| Grt US Holding, INC. | $69.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $61.03 | 2025 | |
| Scilex Pharmaceuticals INC. | $58.99 | 2019 | |
| Nevro Corp. | $37.25 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.10 | 2019-2025 | Relistor |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.18 | 2023 | |
| Fidia Pharma USA INC. | $18.98 | 2019 | |
| Stimwave Technologies Incorporated | $14.28 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.67 | 2019 | |
| Zyla Life Sciences, INC. | $13.48 | 2020 | |
| Allergan, INC. | $12.15 | 2019 | |
| Biodelivery Sciences International, INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aysel Atli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.